LONDON–(BUSINESS WIRE)–ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced data to be presented at the International Congress on Drug Therapy in HIV Infection (HIV Glasgow). It marks ViiV Healthcare’s largest congress presence of the year, with 39 abstracts covering real-world evidence findings for long-acting injectable medicines, pipeline research and patient perspectives. Jean van Wyk, MBChB, MFPM, Chief Medical Officer
